BDBM255771 (3aR,5R,6R,7R,7aR)-5- (hydroxymethyl)-2-(methylamino)- 5,6,7,7a-tetrahydro-3aH-pyrano[3,2- d]thiazole-6,7-diol::US9701693, 1

SMILES CNC1=N[C@H]2[C@H](O[C@H](CO)[C@H](O)[C@@H]2O)S1

InChI Key InChIKey=RPZPRSQYGSVMTF-UHFFFAOYSA-N

Data  1 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 255771   

TargetProtein O-GlcNAcase(Human)
Alectos Therapeutics

US Patent
LigandPNGBDBM255771(US9701693, 1 | (3aR,5R,6R,7R,7aR)-5- (hydroxymethy...)
Affinity DataKi:  243nM ΔG°:  -9.02kcal/moleT: 2°CAssay Description:A variety of tissue culture cell lines, expressing endogenous levels of O-GlcNAcase, can be utilized; examples include rat PC-12, and human U-87, or ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
Go to US Patent